|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01332 TOUYUN BIOTECH
Nominal 
0.154 -0.015 (-8.876%) | 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | 2020/06 HKD(K$) | |
| Turnover | 73,047 | -29.995% | 104,345 | 166,063 | 139,197 | 99,285 |
| Cost of Sales | (41,108) | -39.933% | (68,437) | (107,725) | (84,780) | (60,588) |
| Gross Profit | 31,939 | -11.053% | 35,908 | 58,338 | 54,417 | 38,697 |
| 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | 2020/06 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | (24,458) | |
| Profit / (Loss) before Taxation | (49,145) | -42.237% | (85,081) | (86,308) | (71,874) | (82,706) | |
| Taxation | 326 | -- | (22) | (1,950) | (200) | (6) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 850 | -26.215% | 1,152 | 192 | 10,702 | 491 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | (47,969) | -42.861% | (83,951) | (88,066) | (61,372) | (82,221) | |
| 2024/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | 2020/06 HKD(K$) | |
| Net Finance Costs / (Income) | 4,424 | 8.008% | 4,096 | 20,658 | 8,653 | 16,456 |
| Depreciation & Amortisation | 17,148 | -10.594% | 19,180 | 13,163 | 8,806 | 14,418 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2024/06 - Interim | %Chg (Compare to Interim) | 2023/06 | 2022/06 | 2021/06 | 2020/06 | |
| EPS (cts) | -1.710 | -42.809% | -2.990 | -3.140 | -2.200 | -3.190 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | (0.017) | -- | 0.066 | 0.137 | 0.165 | 0.200 |
| Remarks: | Real time quote last updated: 14/11/2024 15:42 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD -47,969,000 |
| %Change | -42.861% |
| EPS / (LPS) | HKD -0.017 |
| NBV Per Share ($) | HKD -0.017 |